China SXT Pharmaceuticals
SXTC
SXTC
3 hedge funds and large institutions have $78K invested in China SXT Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
3
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$94K | |
| 2 | -$75K | |
| 3 | -$39K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$31K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$15K |